DWT
DGX icon

Dorsey & Whitney Trust’s Quest Diagnostics DGX Stock Holding History

Dorsey & Whitney Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Sell
1,718
-18
-1% -$3.5K 0.02% 532
2025
Q4 		$301K Sell
1,736
-24
-1% -$4.37K 0.02% 557
2025
Q3 		$335K Hold
1,760
– – 0.02% 510
2025
Q2 		$316K Buy
1,760
+43
+3% +$7.47K 0.02% 523
2025
Q1 		$291K Buy
1,717
+87
+5% +$14.3K 0.02% 526
2024
Q4 		$246K Sell
1,630
-7
-0.4% -$1.09K 0.01% 583
2024
Q3 		$254K Buy
1,637
+52
+3% +$7.77K 0.01% 575
2024
Q2 		$217K Sell
1,585
-96
-6% -$13.1K 0.02% 568
2024
Q1 		$224K Buy
1,681
+23
+1% +$2.98K 0.02% 571
2023
Q4 		$229K Buy
+1,658
New +$218K 0.02% 535
2023
Q3 		– Sell
-1,795
Closed -$252K – 594
2023
Q2 		$252K Buy
1,795
+359
+25% +$49.5K 0.02% 485
2023
Q1 		$203K Hold
1,436
– – 0.02% 529
2022
Q4 		$225K Sell
1,436
-358
-20% -$51.4K 0.02% 497
2022
Q3 		$220K Buy
+1,794
New +$236K 0.02% 484
2022
Q1 		– Sell
-1,348
Closed -$233K – 576
2021
Q4 		$233K Buy
+1,348
New +$205K 0.02% 487
2021
Q1 		– Sell
-1,722
Closed -$205K – 528
2020
Q4 		$205K Buy
+1,722
New +$210K 0.02% 442

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Dorsey & Whitney Trust's DGX Position: Q1 2026 in Review

Dorsey & Whitney Trust reduced its Quest Diagnostics (DGX) stake by 1% in Q1 2026, selling an estimated $3.5K and leaving 1,718 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #532.

Dorsey & Whitney Trust first reported a position in DGX in Q4 2020 and has held it in 16 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Dorsey & Whitney Trust held 1,718 shares of Quest Diagnostics worth $337K as of Q1 2026.
  • Dorsey & Whitney Trust sold 18 Quest Diagnostics shares in Q1 2026, an estimated $3.5K.
  • Quest Diagnostics made up 0.02% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #532 holding.
  • Dorsey & Whitney Trust first reported a position in Quest Diagnostics in Q4 2020 and has held it in 16 quarters since.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.